Novo Nordisk’s obesity drug CagriSema reduces weight by 23%
HQ Team June 22, 2025: Novo Nordisk A/S’s data from a clinical trial of a weight-loss medicine, treating overweight and obese adult participants,.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
HQ Team June 22, 2025: Novo Nordisk A/S’s data from a clinical trial of a weight-loss medicine, treating overweight and obese adult participants,.
HQ Team March 8, 2025: A study published in The Lancet by the Global Burden of Disease Study BMI Collaborators reveals alarming statistics.
Obesity is a global concern and the WHO maybe forced add obesity drugs to its essential medicine list
Study says doctors give vague advice on weight loss in consultations
American Gastroentrology Associations recommends 4 approved anti-obesity drugs for people fighting obesity